Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 open-label single-arm study of DA002 oral solution in urea cycle disorders
CTR20253990Phase 3Active
- Sponsor
- 远大医学营养科学（武汉）
- Start
- Dec 2025
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of DA-002 in urea cycle disorder (UCD), sponsored by 远大医学营养科学（武汉）. Started Dec 2025; status: active.
02
Drugs
DA-002
03
Conditions
urea cycle disorder (UCD)
Beyond the preview
Go deeper on CTR20253990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253990.